Perfil epidemiológico de pacientes intoxicados con acetaminofén con intenciones suicidas
Contenido principal del artículo
Resumen
Objetivo: este estudio busca describir los individuos evaluados por sobredosis de acetaminofén entre 2019 y 2020 en un centro de referencia de trasplante hepático en Colombia.
Metodología: estudio derivado del análisis secundario de historias clínicas entre el 1.º de enero de 2019 y el 31 de diciembre de 2020. Los criterios de inclusión abarcan individuos con ingestión aguda y voluntaria de dosis tóxicas de acetaminofén (>4 g/día).
Resultados: sesenta y tres casos, 68% mujeres, 67% menores de 18 años y 54% estudiantes. Reportó historia personal de enfermedad psiquiátrica el 60% y el 35% al menos un intento de suicidio previo. La mediana de dosis de acetaminofén fue 15g, 46% refirieron co-ingesta de otras sustancias y 13% estaba bajo efecto de sustancias psicoactivas. El 57% tenía la intención clara de suicidarse, así como 81% vomitó antes de acudir al servicio de urgencias, 22% recibió medidas de descontaminación y 10% no recibió N - acetilcisteína. Quince individuos desarrollaron lesión hepática aguda, nueve con criterios de severidad.
Conclusiones: la población era predominantemente joven, la historia de enfermedad psiquiátrica fue muy prevalente y la mayoría refirieron un evento vital que explicara el comportamiento impulsivo de consumo. Ninguno desarrolló criterios para trasplante hepático, lo cual podría explicarse por la edad de los individuos, los episodios de vómito temprano, y la ausencia de enfermedad hepática crónica o de consumo de sustancias hepatotóxicas.
Citas
Roberts E, Delgado V, Buckner S, Latchem S, Constanti M, Miller P, et al. Paracetamol: Not as safe as we thought? A systematic literature review of observational studies. Ann Rheum Dis. 2016; 75(3):552–9.
Ghanem CI, Pérez MJ, Manautou JE, Mottino AD. Acetaminophen from liver to brain: New insights into drug pharmacological action and toxicity. Pharmacol Res. 2016; 109:119–31.
Mitchell JR, Jollow DJ, Potter WZ, Davis DC, Gillette JR, Brodie BB. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther. 1973; 187(1):185–94.
Mitchell JR, Jollow DJ, Potter WZ, Gillette JR, Brodie BB. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther. 1973; 187(1):211–7.
Jollow DJ, Mitchell JR, Potter WZ, Davis DC, Gillette JR, Brodie BB. Acetaminophen-induced
hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther. 1973; 187(1):195–202.
Tittarelli R, Pellegrini M, Scarpellini MG, Marinelli E, Bruti V, Di Luca NM, et al. Hepatotoxicity
of paracetamol and related fatalities. Eur Rev Med Pharmacol Sci. 2017; 21(1 Suppl):95–101.
Burcham PC, Harman AW. Acetaminophen toxicity results in site-specific mitochondrial damage
in isolated mouse hepatocytes. J Biol Chem. 1991; 266(8):5049–54.
Meyers LL, Beierschmitt WP, Khairallah EA, Cohen SD. Acetaminophen-induced inhibition of
hepatic mitochondrial respiration in mice. Toxicol Appl Pharmacol. 1988; 93(3):378–87.
WHO. Suicide in the world: Global health estimates. World Health Organization; 2019.
Arenas A, Gómez-Restrepo C, Rondón M. Factores asociados a la conducta suicida en
Colombia. Resultados de la Encuesta Nacional de Salud Mental 2015. Rev Colomb Psiquiat.
;45(S1):68–75.
Instituto Nacional de Salud. Datos abiertos Colombia [Internet]. SIVIGILA. 2019 [citado 17
de mayo de 2021]. Disponible en: https://www.datos.gov.co/Salud-y-Protecci-n-Social/
SIVIGILA-2019/qvnt-2igj
Subdirección de Vigilancia en Salud Pública. [Intoxication with chemical substances during
second semester of 2018-Bogotá, D. C]. Bogotá, D.C.; 2019.
Aithal GP, Watkins PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, et al. Case definition and
phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther. 2011; 89(6):806–15.
Fontana RJ, Seeff LB, Andrade RJ, Björnsson E, Day CP, Serrano J, et al. Standardization of
nomenclature and causality assessment in drug-induced liver injury: Summary of a clinical
research workshop. Hepatology (Baltimore, Md.). 2010; 52:730–42.
Yu YC, Mao YM, Chen CW, Chen JJ, Chen J, Cong WM, et al. CSH guidelines for the diagnosis
and treatment of drug-induced liver injury. Hepatology international. 2017; 11:221–41.
Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Brooks DE, Dibert KW, et al. 2019 Annual
Report of the American Association of Poison Control Centers’ National Poison Data System
(NPDS): 37th Annual Report. Clin Toxicol (Phila). 2020; 58(12):1360–541.
Licata A, Minissale MG, Calvaruso V, Craxì A. A focus on epidemiology of drug-induced liver
injury: Analysis of a prospective cohort. Eur Rev Med Pharmacol Sci. 2017; 21(1 Suppl):112–21.
Blieden M, Paramore LC, Shah D, Ben-Joseph R. A perspective on the epidemiology of
acetaminophen exposure and toxicity in the United States. Expert Rev Clin Pharmacol.
;7(3):341–8.
Hawton K, Ware C, Mistry H, Hewitt J, Kingsbury S, Roberts D, et al. Paracetamol self-poisoning
characteristics, prevention and harm reduction. Br J Psychiatry. 1996; 168(1):43–8.
Kingsbury S, Hawton K, Steinhardt K, James A. Do adolescents who take overdoses have specific
psychological characteristics? A comparative study with psychiatric and community controls.
J Am Acad Child Adolesc Psychiatry. 1999; 38(9):1125–31.
Myers RP, Li B, Fong A, Shaheen AA, Quan H. Hospitalizations for acetaminophen overdose: A
Canadian population-based study from 1995 to 2004. BMC Public Health. 2007; 7:143.
UK Legislation. The Medicines (Sale or Supply) (Miscellaneous Provisions) Amendment (No. 2)
Regulations 1997 [Internet]. 1997 [citado el 17 de mayo de 2021]. Disponible en: https://www.
legislation.gov.uk/uksi/1997/2045/contents/made
Morgan O, Majeed A. Restricting paracetamol in the United Kingdom to reduce poisoning: A
systematic review. J Public Health. 2005; 27(1):12–8.
Heard KJ. Acetylcysteine for acetaminophen poisoning. N Engl J Med. 2008; 359(3):285–92.
Duffull SB, Isbister GK. Predicting the requirement for N-acetylcysteine in paracetamol poisoning
from reported dose. Clin Toxicol. 2013; 51(8):772–6.
Patterson WM, Dohn HH, Bird J, Patterson GA. Evaluation of suicidal patients: The SAD PERSONS
scale. Psychosomatics. 1983; 24(4):343-5.
Katz C, Randall JR, Sareen J, Chateau D, Walld R, Leslie WD, et al. Predicting suicide with the
SAD PERSONS scale. Depress Anxiety. 2017; 34(9):809–16.
David S, Hamilton JP. Drug-induced Liver Injury. US Gastroenterol Hepatol Rev. 2010; 6:73–80.
Biolato M, Araneo C, Marrone G, Liguori A, Miele L, Ponziani FR, et al. Liver transplantation for
drug-induced acute liver failure. Eur Rev Med Pharmacol Sci. 2017; 21(1 Suppl):37–45.
Schmidt LE, Larsen FS. MELD score as a predictor of liver failure and death in patients with
acetaminophen-induced liver injury. Hepatology. 2007; 45(3):789–96.
Chefirat B, Zergui A, Rahmani C, Belmessabih MN, Rezk-Kallah H. Acute paracetamol poisonings
received at the Oran University Hospital. Toxicol Reports. 2020; 7:1172–7.
Bateman DN, Dear JW. Acetylcysteine in paracetamol poisoning: A perspective of 45 years of
use. Toxicol Res. 2019; 8(4):489–98.
Chiew AL, Gluud C, Brok J, Buckley NA. Interventions for paracetamol (acetaminophen) overdose.
Cochrane database Syst Rev. 2018; 2(2):CD003328.
Slattery JT, Nelson SD, Thummel KE. The complex interaction between ethanol and
acetaminophen. Clin Pharmacol Ther. 1996; 60(3):241–6.
Waring WS, Stephen AF, Malkowska AM, Robinson ODG. Acute ethanol coingestion confers a
lower risk of hepatotoxicity after deliberate acetaminophen overdose. Acad Emerg Med Off
J Soc Acad Emerg Med. 2008; 15(1):54–8.
Yoon E, Babar A, Choudhary M, Kutner M, Pyrsopoulos N. Acetaminophen-Induced
Hepatotoxicity: A Comprehensive Update. J Clin Transl Hepatol. 2016; 4(2):131–42.
Hodgman MJ, Garrard AR. A review of acetaminophen poisoning. Crit Care Clin. 2012; 28(4):499–
Dart RC, Erdman AR, Olson KR, Christianson G, Manoguerra AS, Chyka PA, et al. Acetaminophen
poisoning: An evidence-based consensus guideline for out-of-hospital management. Clin
Toxicol. 2006; 44(1):1–18.
Chun LJ, Tong MJ, Busuttil RW, Hiatt JR. Acetaminophen hepatotoxicity and acute liver failure.
J Clin Gastroenterol. 2009; 43(4):342–9.
Tajiri K, Shimizu Y. Practical guidelines for diagnosis and early management of drug-induced
liver injury. World J Gastroenterol. 2008; 14(44):6774–85.
van Heeringen K. Stress–diathesis model of suicidal behavior. In The neurobiological basis of
suicide. Dwivedi Y, editor. Boca Raton (FL); 2012.